Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

NEW YORK, December 31, 2025, 08:41 ET — Premarket

  • Ambev’s U.S.-listed shares were down 0.8% in premarket trade after closing up 2.5% on Tuesday.
  • Investors are parsing the impact of a cash dividend paid on Dec. 30 and the timing of a separate payout tied to “interest on own capital.”
  • The next scheduled catalyst on the company calendar is Ambev’s 4Q25 earnings release on Feb. 12.

Ambev S.A. shares were down 0.8% at $2.461 in premarket trading, after ending Tuesday up 2.5% at $2.48. The ADR has traded between $2.28 and $2.60 in recent sessions, reflecting choppy year-end positioning. StockAnalysis

The timing matters because late-December trading can amplify small flows, especially in high-yield stocks where investors are repositioning around payouts. For Ambev, the week’s dividend schedule has been the main company-specific marker on screens.

Ambev told investors in a U.S. securities filing that its board approved dividends of 0.4612 reais per share, “to be made on December 30, 2025,” and said the payment would be made without withholding tax at the source. In the same notice, it also approved “interest on own capital” (IOC) of 0.2690 reais per share — a Brazil-specific shareholder distribution — with the payment date to be set later and made by Dec. 31, 2026. SEC

IOC is essentially a dividend-style payout that Brazilian companies can treat as a tax-efficient distribution, but it is typically subject to withholding, unlike regular dividends. Ambev said the IOC would result in a net distribution of 0.2286 reais per share after taxes. SEC

The stock is hovering below its 52-week high after a late-December dip that followed its ex-dividend period — the date after which new buyers are no longer entitled to receive the declared payout. ABEV’s 52-week range is $1.76 to $2.635, according to MarketWatch data. MarketWatch

The last major fundamental catalyst came in late October, when Ambev beat third-quarter profit forecasts and announced a share buyback program, while warning of weaker industry demand as volumes slipped. Reuters

Next up, Ambev’s investor relations calendar lists its 4Q25 earnings release for Feb. 12, 2026, followed by corporate governance milestones including a management proposal and call notice on March 30 and the annual shareholders’ meeting on April 30. Ambev

In the run-up to those results, investors will be watching signs of demand in Brazil beer, the company’s ability to push pricing without sacrificing volumes, and whether costs are easing or tightening into 2026. Currency moves also matter for ADR holders because distributions declared in reais are converted into dollars for payment.

Ambev’s U.S.-listed instrument is an American Depositary Share (ADS) that represents one common share, Nasdaq’s description of the program shows. That means payout mechanics and record dates for the ADS tend to track the Brazilian share distribution, with the depositary handling conversion. Nasdaq

With the regular session still ahead, traders will be watching whether premarket softness carries into the open, and whether volume remains subdued heading into the New Year holiday stretch.

Stock Market Today

  • SO Stock Today: Alabama Power Ash Risks Could Shape 2026 Costs for Southern Co.
    December 31, 2025, 9:30 AM EST. Alabama Power's unlined coal ash ponds at Plant Barry raise breach and groundwater risks that could affect Southern Company (SO). Investors weigh cleanup capex, possible ash recycling, and how much cost recovery regulators may allow in 2026. SO last traded at $87.54, with a 21.8x P/E and a 3.37% dividend yield; Street consensus targets roughly $93.22. The report outlines remediation paths: excavating ash to lined landfills, on-site consolidation with liners, or recycling into cement. Financials show negative free cash flow per share (-$1.81) and capex to revenue of 0.39; debt-to-equity 1.89; interest coverage 2.46; payout ratio 67%. Regulatory recoveries could arrive via 2026 filings, with outcomes depending on scope approved and pacing; legal actions could extend timelines and add costs.
Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus
Previous Story

Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise
Next Story

Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

Go toTop